Complete coverage on

Osiris Therapeutics Inc.

Latest Stories

CNNMoney: Stem cell studies won't sway Big Pharma: expertsupdated: Wed Nov 21 2007 14:20:00

The recent breakthroughs in stem cell research, where adult cells were "reprogrammed" to act like embryonic stem cells, are too early-stage to have much influence on Big Pharma's venture capital investments, experts say.

CNNMoney: Biotechs in flux after cell breakthroughupdated: Tue Nov 20 2007 14:35:00

Biotech stocks were volatile Tuesday after separate teams of researchers said they have "reprogrammed" adult cells to mimic the properties of human embryonic stem cells - side-stepping the controversy associated with their use in the search for cures of many diseases and afflictions.

CNNMoney: Stem cell stocks volatile after Senate voteupdated: Thu Apr 12 2007 10:43:00

Some of the biotechs specializing in stem cell research took a hit Thursday after the Senate voted to remove a ban on federal funding for embryonic stem cell research but not by a wide enough margin to overcome an expected presidential veto.

CNNMoney: New stem cell treatments on the wayupdated: Thu Apr 05 2007 09:17:00

Two new stem cell treatments could be entering the U.S. market next year.

CNNMoney: Mo. stem cell vote aids biotechsupdated: Tue Nov 07 2006 15:49:00

The results of Missouri's referendum on stem cell research Tuesday could impact several biotechs specializing in that line of work.

Fortune: New Research Is An Easier Cellupdated: Mon Mar 18 2002 00:01:00

It's hard to imagine pro-lifers and medical researchers ever seeing eye-to-eye on stem cell research (or anything else, for that matter). But a promising new study has led to talk of a detente.

We recommend